These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 20816959)

  • 1. Temozolomide/PLGA microparticles plus vatalanib inhibits tumor growth and angiogenesis in an orthotopic glioma model.
    Zhang YH; Yue ZJ; Zhang H; Tang GS; Wang Y; Liu JM
    Eur J Pharm Biopharm; 2010 Nov; 76(3):371-5. PubMed ID: 20816959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temozolomide/PLGA microparticles: a new protocol for treatment of glioma in rats.
    Zhang YH; Zhang H; Liu JM; Yue ZJ
    Med Oncol; 2011 Sep; 28(3):901-6. PubMed ID: 20396980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temozolomide/PLGA microparticles and antitumor activity against glioma C6 cancer cells in vitro.
    Zhang H; Gao S
    Int J Pharm; 2007 Feb; 329(1-2):122-8. PubMed ID: 17000068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination treatment with temozolomide and thalidomide inhibits tumor growth and angiogenesis in an orthotopic glioma model.
    Son MJ; Kim JS; Kim MH; Song HS; Kim JT; Kim H; Shin T; Jeon HJ; Lee DS; Park SY; Kim YJ; Kim JH; Nam DH
    Int J Oncol; 2006 Jan; 28(1):53-9. PubMed ID: 16327979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metronomic treatment of temozolomide inhibits tumor cell growth through reduction of angiogenesis and augmentation of apoptosis in orthotopic models of gliomas.
    Kim JT; Kim JS; Ko KW; Kong DS; Kang CM; Kim MH; Son MJ; Song HS; Shin HJ; Lee DS; Eoh W; Nam DH
    Oncol Rep; 2006 Jul; 16(1):33-9. PubMed ID: 16786120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic inhibition of angiogenesis and glioma cell-induced angiogenesis by the combination of temozolomide and enediyne antibiotic lidamycin.
    Li XQ; Ouyang ZG; Zhang SH; Liu H; Shang Y; Li Y; Zhen YS
    Cancer Biol Ther; 2014 Apr; 15(4):398-408. PubMed ID: 24424202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiangiogenic agent, thalidomide increases the antitumor effect of single high dose irradiation (gamma knife radiosurgery) in the rat orthotopic glioma model.
    Lee JI; Itasaka S; Kim JT; Nam DH
    Oncol Rep; 2006 May; 15(5):1163-8. PubMed ID: 16596180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination celecoxib and temozolomide in C6 rat glioma orthotopic model.
    Kang SG; Kim JS; Park K; Kim JS; Groves MD; Nam DH
    Oncol Rep; 2006 Jan; 15(1):7-13. PubMed ID: 16328028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual Anti-angiogenic Chemotherapy with Temozolomide and Celecoxib in Selected Patients with Malignant Glioma Not Eligible for Standard Treatment.
    Kerschbaumer J; Schmidt FA; Grams AE; Nowosielski M; Pinggera D; Brawanski KR; Petr O; Thomé C; Tuettenberg J; Seiz M; Freyschlag CF
    Anticancer Res; 2015 Sep; 35(9):4955-60. PubMed ID: 26254394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of anti-tumor activity by low-dose combination of the recombinant urokinase kringle domain and celecoxib in a glioma model.
    Kim CK; Joe YA; Lee SK; Kim EK; O E; Kim HK; Oh BJ; Hong SH; Hong YK
    Cancer Lett; 2010 Feb; 288(2):251-60. PubMed ID: 19664879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid (anti-18F-FACBC) is a feasible alternative to 11C-methyl-L-methionine and magnetic resonance imaging for monitoring treatment response in gliomas.
    Sasajima T; Ono T; Shimada N; Doi Y; Oka S; Kanagawa M; Baden A; Mizoi K
    Nucl Med Biol; 2013 Aug; 40(6):808-15. PubMed ID: 23701701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. iNGR-modified PEG-PLGA nanoparticles that recognize tumor vasculature and penetrate gliomas.
    Kang T; Gao X; Hu Q; Jiang D; Feng X; Zhang X; Song Q; Yao L; Huang M; Jiang X; Pang Z; Chen H; Chen J
    Biomaterials; 2014 May; 35(14):4319-32. PubMed ID: 24565520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current evidence of temozolomide and bevacizumab in treatment of gliomas.
    Nanegrungsunk D; Onchan W; Chattipakorn N; Chattipakorn SC
    Neurol Res; 2015 Feb; 37(2):167-83. PubMed ID: 25033940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new anti-glioma therapy, AG119: pre-clinical assessment in a mouse GL261 glioma model.
    Towner RA; Ihnat M; Saunders D; Bastian A; Smith N; Pavana RK; Gangjee A
    BMC Cancer; 2015 Jul; 15():522. PubMed ID: 26177924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the efficiency of chemotherapy in in vivo orthotopic models of human glioma cells with and without 1p19q deletions and in C6 rat orthotopic allografts serving for the evaluation of surgery combined with chemotherapy.
    Branle F; Lefranc F; Camby I; Jeuken J; Geurts-Moespot A; Sprenger S; Sweep F; Kiss R; Salmon I
    Cancer; 2002 Aug; 95(3):641-55. PubMed ID: 12209758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenesis in malignant glioma--a target for antitumor therapy?
    Tuettenberg J; Friedel C; Vajkoczy P
    Crit Rev Oncol Hematol; 2006 Sep; 59(3):181-93. PubMed ID: 16860996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temozolomide combined with PD-1 Antibody therapy for mouse orthotopic glioma model.
    Dai B; Qi N; Li J; Zhang G
    Biochem Biophys Res Commun; 2018 Jul; 501(4):871-876. PubMed ID: 29758196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sunitinib impedes brain tumor progression and reduces tumor-induced neurodegeneration in the microenvironment.
    Hatipoglu G; Hock SW; Weiss R; Fan Z; Sehm T; Ghoochani A; Buchfelder M; Savaskan NE; Eyüpoglu IY
    Cancer Sci; 2015 Feb; 106(2):160-70. PubMed ID: 25458015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced interstitial chemotherapy combined with targeted treatment of malignant glioma in rats by using drug-loaded nanofibrous membranes.
    Tseng YY; Su CH; Yang ST; Huang YC; Lee WH; Wang YC; Liu SC; Liu SJ
    Oncotarget; 2016 Sep; 7(37):59902-59916. PubMed ID: 27494894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABT-510, a modified type 1 repeat peptide of thrombospondin, inhibits malignant glioma growth in vivo by inhibiting angiogenesis.
    Anderson JC; Grammer JR; Wang W; Nabors LB; Henkin J; Stewart JE; Gladson CL
    Cancer Biol Ther; 2007 Mar; 6(3):454-62. PubMed ID: 17384534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.